These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15828172)

  • 1. R-mediated beta-lactamases and episomal resistance to the beta-lactam drugs in different bacterial hosts.
    Kontomichalou PM; Papachristou EG; Levis GM
    Antimicrob Agents Chemother; 1974 Jul; 6(1):60-72. PubMed ID: 15828172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to beta-lactam antibiotics Proteus strains.
    Lachmajer-Lutoslawska M; Bobrowski M
    Acta Microbiol Pol A; 1975; 8(3):141-9. PubMed ID: 1103580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of beta-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital.
    Chanal C; Bonnet R; De Champs C; Sirot D; Labia R; Sirot J
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1930-5. PubMed ID: 10858357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactamase-directed barrier for penicillins of Escherichia coli carrying R plasmids.
    Yamamoto T; Yokota T
    Antimicrob Agents Chemother; 1977 Jun; 11(6):936-40. PubMed ID: 327924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of TEM mutants in Proteus mirabilis.
    Bonnet R; De Champs C; Sirot D; Chanal C; Labia R; Sirot J
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2671-7. PubMed ID: 10543745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple phenotypic method for differentiation between acquired and chromosomal AmpC beta-lactamases in Escherichia coli.
    Mirelis B; Rivera A; Miró E; Mesa RJ; Navarro F; Coll P
    Enferm Infecc Microbiol Clin; 2006; 24(6):370-2. PubMed ID: 16792938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-lactamases and R-plasmids of Haemophilus influenzae.
    Saunders JR; Elwell LP; Falkow S; Sykes RB; Richmond MH
    Scand J Infect Dis Suppl; 1978; (13):16-22. PubMed ID: 308259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and prevalence of the different mechanisms of resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli.
    Medeiros AA; Kent RL; O'Brien TF
    Antimicrob Agents Chemother; 1974 Dec; 6(6):791-801. PubMed ID: 4615632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae.
    Tzouvelekis LS; Tzelepi E; Mentis AF; Tsakris A
    J Antimicrob Chemother; 1993 May; 31(5):645-54. PubMed ID: 8335495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo transferrable beta-lactam resistance due to a new plasmid-mediated oxyiminocephalosporinase from a clinical isolate of Proteus mirabilis.
    Watanabe Y; Yokota T; Higashi Y; Wakai Y; Mine Y
    Microbiol Immunol; 1991; 35(2):87-97. PubMed ID: 1886493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characterization by zymograms of R factor-determined beta-lactamases: plasmids of defined and undefined compatibility groups (author's transl)].
    Laub-Kupersztejn R; Antoine O; Pohl P; Thomas J
    Ann Microbiol (Paris); 1976; 127A(2):237-46. PubMed ID: 786104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carbenicillin resistance of gram-negative bacteria: incidence, biochemical and genetic determinism].
    Shaokat S; Joly B; Philippon A; Sirot D; Cluzel R
    Pathol Biol (Paris); 1985 Oct; 33(8):825-9. PubMed ID: 3903620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa.
    Pitout JD; Thomson KS; Hanson ND; Ehrhardt AF; Moland ES; Sanders CC
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1350-4. PubMed ID: 9624474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3.
    Neuwirth C; Madec S; Siebor E; Pechinot A; Duez JM; Pruneaux M; Fouchereau-Peron M; Kazmierczak A; Labia R
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3591-4. PubMed ID: 11709345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid-mediated carbencillin hydrolyzing beta-lactamases of Proteus mirabilis.
    Katsu K; Inoue M; Mitsuhashi S
    J Antibiot (Tokyo); 1981 Nov; 34(11):1504-5. PubMed ID: 7033194
    [No Abstract]   [Full Text] [Related]  

  • 18. IRT and CMT beta-lactamases and inhibitor resistance.
    Cantón R; Morosini MI; de la Maza OM; de la Pedrosa EG
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():53-62. PubMed ID: 18154528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
    Vanjak D; Muller-Serieys C; Picard B; Bergogne-Berezin E; Lambert-Zechovsky N
    Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):972-8. PubMed ID: 8654448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-spectrum beta-lactamase in Proteus mirabilis.
    Mariotte S; Nordmann P; Nicolas MH
    J Antimicrob Chemother; 1994 May; 33(5):925-35. PubMed ID: 8089066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.